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Introduction
The mainstay of current schistosomiasis control is preventive chemotherapy (PC) with prazi-
quantel, targeted toward school-aged children, based on the disease endemicity within a subset
of surveyed schools, which are classified using parasitological prevalence and intensity of infec-
tions [1]. However, it is well known that the current conventional mapping design for schisto-
somiasis has shown several limitations and may lead to several uncertainties and
misclassification of some districts and their eligibility for PC. These inaccuracies prevent suc-
cessful PC coverage of all populations that need treatment and, therefore, jeopardise the
achievement of schistosomiasis elimination [2]. Our recent studies have revealed that precision
mapping of schistosomiasis is an essential requirement to move from disease control toward
interruption of schistosome transmission in sub-Saharan Africa. As schistosomiasis is a focal
disease geographically, having a high-resolution map is necessary if current or future interven-
tions are to be targeted accordingly. Precision mapping is defined as conducting sampling at a
much finer geographical resolution, potentially examining all schools within every subunit in
each implementation unit in order to eliminate the errors caused by missing the focal variation
in schistosomiasis prevalence. Indeed, current mapping protocols and sampling frames per-
form badly when assessing this landscape.
Limitations and uncertainties of the current mapping design for
schistosomiasis
In the current World Health Organization-recommended (WHO) mapping design, in each
health district (i.e., the implementation unit), a sub-sample of up to five schools and 50 chil-
dren per school are selected for parasitological surveys. The eligibility of the district for PC is
then determined by the mean prevalence that allows the entire district to be classified as
nonendemic (= 0%), low (<10%), moderate (10% to<50%), or high risk (50%) for schisto-
somiasis [1]. Although this approach has been suitable in the past, within the context of mor-
bidity control and paucity of drug availability and funding, it is currently not suitable for
achieving the schistosomiasis elimination goal and WHO roadmap targets. Indeed, due to the
high focality of schistosomiasis transmission and its dependence on several epidemiological
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and ecological factors (e.g., climatic and physical conditions, type of water bodies, susceptible
intermediate snail species and population dynamics, impact of reservoir hosts, intensity of
water contacts, etc.) [3], there exists significant difference in infection prevalence between sub-
settings and schools within the same health districts. The selection of only a few schools to
decide for the entire district’s endemicity leads to some uncertainties and errors if the site
selection and sampling are not properly undertaken. In this context, a misclassification of dis-
tricts and the subsequent decision to implement mass PC or not may result in overtreatment
in some areas and, most importantly, undertreatment or no treatment in areas that need it
most (Fig 1). Examples of the limitations of the current schistosomiasis-mapping design and
its impact on the determination of health district eligibility for mass PC in Cameroon have
been highlighted in a recent publication by Tchuem Tchuente´ and colleagues [2].
Precision mapping of schistosomiasis
Without clear knowledge of disease transmission foci, countries are not able to adequately
plan interventions for schistosomiasis elimination, often requiring sustained long-term efforts.
The mapping of disease foci distributions is a critical step in understanding where at-risk pop-
ulations live, therefore, more accurate mapping is a prerequisite for effective and higher impact
control interventions. As schistosomiasis elimination moves forward, there is a need to map
more geographical points to deepen the understanding of disease distribution and to guide
decision-making. To assess the role precision mapping could play in the stages of moving
toward elimination of schistosomiasis, we recently conducted a preliminary study in two
health districts in Cameroon, i.e., Edea in the Littoral region, a low-transmission area for the
rectal schistosomiasis Schistosoma guineensis [4], and Ndikinimeki in the Centre region, where
there occurs a high transmission of intestinal schistosomiasis S. mansoni [5]. Using this new
and innovative approach, the study consisted of an exhaustive sampling of all schools (mater-
nal, primary, and secondary) in each of these two districts. A total of 126 and 108 schools and
7,470 and 3,463 school children were sampled in the Edea and Ndikinimeki health districts,
respectively. School infection prevalence ranged from 0% to 15% in Edea and 0% up to 50% in
Ndikinimeki. The point prevalence of schistosomiasis in all surveyed schools, shown in Fig 1,
clearly illustrates the distribution of the disease in each district. The maps show significant var-
iations in schistosomiasis prevalence within health districts and subdistricts. The majority of
schools were negative for schistosomiasis. For each district, a comparison of maps obtained
using the ‘conventional’ mapping method with those from precision mapping shows signifi-
cant differences. The precision map illustrates the high focality of schistosomiasis transmission
and clearly provides detailed information on high-risk zones and locations where intensified
interventions should be focused primarily to obtain higher impact. For example, the health dis-
trict of Edea is subdivided into 11 health areas, with a total PC-targeted population of 119,157.
Interestingly, precision mapping clearly revealed that schistosomiasis occurs in six health
areas, and only one health area had an infection prevalence above 10% (the minimum thresh-
old for mass PC for morbidity control). Therefore, the PC-targeted population will be reduced
to 12,288 for a morbidity control target or to 91,396, in case the program has the ambition to
interrupt the transmission of schistosomiasis. Consequently, the drug needs will be signifi-
cantly reduced as well. This is the first description of precision mapping of schistosomiasis in
Cameroon. However, as the schistosomiasis prevalence may vary significantly from one dis-
trict to another, the subsequent gains may also vary. Therefore, further studies are required to
allow adequate assessment of cost-effectiveness and strategy optimisation of precision
mapping.
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Priority interventions for schistosomiasis elimination
On March 22–23, 2017, experts attending the international conference on schistosomiasis in
Cameroon, entitled ‘Towards elimination of schistosomiasis: A paradigm shift’, endorsed the
precision-mapping approach as one of the priority interventions for schistosomiasis elimina-
tion. The conference provided a platform to access all that was new, evolving, challenging, suc-
cessful, and exciting in schistosomiasis control and elimination. Looking forward to the 2020/
2025 WHO roadmap targets and the World Health Assembly WHA65.21 resolution on elimi-
nation of schistosomiasis, the conference endorsed the WHO Regional Office for the Africa
‘PHASE approach’, which refers to integrated implementation of a package of PC, health
Fig 1. Comparison of precision and conventional maps of schistosomiasis prevalence in the health districts of
Edea (A) and Ndikinimeki (B), Cameroon. The precision maps (A1 and B1) provide more accurate information on
the distribution of schistosomiasis within districts and a clear precision on subdistricts or communities requiring
preventive chemotherapy. Differences of subdistrict prevalence between 1985 and 2010 mappings further illustrate the
limitations and uncertainties of the conventional mapping (A2 versus A3 and B2 versus B3). Produced with Esri
ArcGIS Pro 2.0.
https://doi.org/10.1371/journal.pntd.0006563.g001
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education, access to safe drinking water, sanitation and hygiene, and environmental improve-
ment [6]. The conference put forward four recommendations for priority interventions to
move toward schistosomiasis elimination: (i) to expand general access to praziquantel treat-
ment by extending mass PC to preschool-aged children and adults and by increasing the avail-
ability of medicines in health centres and treatment stations throughout the year to ensure that
all those who seek treatment can receive it; (ii) to complete precision mapping to provide
high-resolution information to better focus and tailor PC, to adapt treatment strategies to
schistosomiasis transmission dynamics, and, where necessary, to introduce biannual treatment
as intensification of current PC campaigns; (iii) to intensify multisectoral actions, which con-
solidate control and elimination of schistosomiasis that specifically upscale and foster sustain-
ability of PHASE activities; and (iv) to encourage community ownership of the programme
with appropriate communication and health education tools that nurture a closer partnership
between local and national stakeholders engaged in cross-sectorial actions [7].
Conclusion
Precision mapping of schistosomiasis gives high-resolution information at the local level. By
increasing the map granularity and spatial resolution, precision mapping provides the best evi-
dence-based data to guide intensified interventions in targeted transmission zones and allows
for a better and rational utilization of the donated praziquantel and available resources. We
therefore believe that it is a promising and innovative tool to shrink the map of schistosomiasis
and accelerate the move toward the elimination of schistosomiasis.
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